Title Issue Date
The cardiovascular event risk associated with Tyrosine Kinase Inhibitors and the lipid rrofile in patients with chronic myeloid leukemia Saez Perdomo, María Nieves; Stuckey, Ruth; González-Pérez, Elena; Sánchez-Sosa, Santiago; Estupiñan-Cabrera, Paula, et al Issued date: 2024 DOI: 10.3390/hematolrep16010015 Source: Hematology Reports [ISSN 2038-8322], v. 16 (1), p. 140-150, (Marzo 2024). SJR: 0,263 - Q4 ESCI MIAR ICDS: 9,6 Artículo
TKI Use and Treatment-Free Remission in Chronic Myeloid Leukemia: Evidence from a Regional Cohort Study in the Canary Islands Sánchez Sosa, José Santiago ; Stuckey, Ruth; Segura Díaz, Adrian ; Gonzalez San Miguel, Jose David; Morales Ruiz, Ylenia, et al Issued date: 2025 DOI: 10.3390/hematolrep17040039 Source: Hematology Reports [ISSN 2038-8322], v. 17 (4), (Agosto 2025) SJR: 0,263 - Q4 ESCI MIAR ICDS: 9,6 Artículo
Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia Herrera-Hernández, Carol; Segura Díaz, Adrian ; Stuckey, Ruth; López Rodríguez, Juan Francisco ; Gómez Casares, María Teresa Issued date: 2025 DOI: 10.3390/hematolrep17050047 Source: Hematology Reports[ISSN 2038-8322],v. 17 (5), (Octubre 2025) SJR: 0,263 - Q4 ESCI MIAR ICDS: 9,6 Artículo